VolitionRx Limited APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
VolitionRx Limited (VNRX) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $2.29 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-25.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2024-03-25
- VolitionRx Limited apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $2.29M, a 26.49% decline from fiscal 2022.
- VolitionRx Limited apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $3.11M.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|
| 2023-12-31 | $2.29M 10-K · filed 2024-03-25 |
| 2022-12-31 | $3.11M 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |